Titre (en)
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « benefit »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
beneficial < benefit < benefits  Facettes :

List of bibliographic references indexed by benefit

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000073 (2021) Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France]Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000301 (2021) Kenneth Sands [États-Unis] ; Richard Wenzel [États-Unis] ; Laura Mclean [États-Unis] ; Kimberly Korwek [États-Unis] ; Jonathon Roach [États-Unis] ; Karla Miller [États-Unis] ; Russell E. Poland [États-Unis] ; L Hayley Burgess [États-Unis] ; Edmund Jackson [États-Unis] ; Jonathan B. Perlin [États-Unis]No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
000601 (2021) Van Thuan Hoang [Viêt Nam]Comment to Sands et al. - No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
000824 (2020) Dr Subodh Kumar Pathak [Inde] ; Dr Abhijeet Ashok Salunke [Inde] ; Dr Praveen Thivari [Inde] ; Apurva Pandey [Inde] ; Dr Kunal Nandy [Inde] ; Dr Harish V K Ratna [Inde] ; Dr Sanjay Pandey [Inde] ; Dr Jasneet Chawla [Inde] ; Dr Jalil Mujawar [Inde] ; Dr Anant Dhanwate [Inde] ; Dr Vivek Menon [Inde]No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".
000A95 (2020) Giovanna Liuzzo ; Carlo PatronoThe widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
000F29 (2020) J M Molina [France] ; C. Delaugerre [France] ; J. Le Goff [France] ; B. Mela-Lima [France] ; D. Ponscarme [France] ; L. Goldwirt [France] ; N. De Castro [France]No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
000F30 (2020) Klinger Soares Faíco-Filho [Brésil] ; Danielle Dias Conte [Brésil] ; Luciano Kleber De Souza Luna [Brésil] ; Joseane Mayara Almeida Carvalho [Brésil] ; Ana Helena Sitta Perosa [Brésil] ; Nancy Bellei [Brésil]No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19.
001030 (2020) Hoyt Burdick [États-Unis] ; Carson Lam [États-Unis] ; Samson Mataraso [États-Unis] ; Anna Siefkas [États-Unis] ; Gregory Braden [États-Unis] ; R Phillip Dellinger [États-Unis] ; Andrea Mccoy [États-Unis] ; Jean-Louis Vincent [Belgique] ; Abigail Green-Saxena [États-Unis] ; Gina Barnes [États-Unis] ; Jana Hoffman [États-Unis] ; Jacob Calvert [États-Unis] ; Emily Pellegrini [États-Unis] ; Ritankar Das [États-Unis]Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY Trial.
001228 (2020) Lara Bull-Otterson ; Elizabeth B. Gray ; Daniel S. Budnitz ; Heather M. Strosnider ; Lyna Z. Schieber ; Joseph Courtney ; Macarena C. García ; John T. Brooks ; William R. Mac Kenzie ; Adi V. GundlapalliHydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.
001414 (2020) Tejas K. Patel [Inde] ; Manish Barvaliya [Inde] ; Bhavesh D. Kevadiya [États-Unis] ; Parvati B. Patel [Inde] ; Hira Lal Bhalla [Inde]Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
001415 (2020) Tejas K. Patel [Inde] ; Manish Barvaliya [Inde] ; Bhavesh D. Kevadiya [États-Unis] ; Parvati B. Patel [Inde] ; Hira Lal Bhalla [Inde]Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
001464 (2020) Ingrid Torjesen [Royaume-Uni]Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds.
001839 (2020) E H Decloedt [Afrique du Sud] ; H. Reuter ; B. Allwood ; A. Parker ; C F N. Koegelenberg ; M. Blockman ; J. TaljaardBenefit v. risk when using chloroquine in patients with severe COVID-19 disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "benefit" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "benefit" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    benefit
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021